| Document |
Document Title |
|
JP2014015341A |
To provide a system for producing ammonia and methanol, which is capable of improving the production efficiency of ammonia and methanol while suppressing an increase in the production cost of both ammonia and methanol.A system 10 for pro...
|
|
JP5378361B2 |
An enhanced process is described for the synthesis of urea from ammonia and carbon dioxide, at a high pressure and temperature, with the formation of ammonium carbamate as intermediate, which includes a high pressure synthesis section, c...
|
|
JP5373771B2 |
The invention relates to a process for the synthesis of (Z)-3-[2-butoxy-3′-(3-heptyl-1-methylureido)biphenyl-4-yl]
-2-methoxyacrylic acid of formula (I): and also to the process for the synthesis of the reaction intermediates of genera...
|
|
JP5356825B2 |
The present invention relates to 2-adamantylurea derivatives of formula I as selective inhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and the use of such compounds for the treatment and prevention of met...
|
|
JP5351138B2 |
Isocyanate and aldimine group-carrying compounds (I), are new. Isocyanate and aldimine group-carrying compounds of formula ((OCN) u-Q-(NH-C(=O)-NH-X-N=CH-Y 1>) v) (I), are new. Q : polyisocyanate with (u+v) terminal isocyanate group afte...
|
|
JP5355089B2 |
Biaromatic compounds (I) and their salts, solvates and/or hydrates, are new. Biaromatic compounds of formula (I) and their salts, solvates and/or hydrates, are new. R1 : -OR6, -NR6-OR6 or -NR6R6; R2 : halo, 1-12C alkyl, -OR7, -NHR7 or ar...
|
|
JP5338488B2 |
To provide a method for producing high-purity urea water excellent in transparency and also suitable as a source of ammonia in an NOx reduction catalyst for internal combustion engine exhaust treatment using urea containing an impurity w...
|
|
JP5291854B2 |
The present invention provides a method represented by Scheme 1: wherein X represents I, Br, Cl, alkylsulfonate, or arylsulfonate; Z represents optionally substituted aryl, heteroaryl or alkenyl; L represents hydrogen or a negative charg...
|
|
JP2013177344A |
To provide an achiral liquid crystal compound showing ferroelectricity, having high-speed electric field response and a high threshold of polarization inversion, and showing a liquid crystal phase in which a polarization state does not d...
|
|
JP2013173784A |
To provide a multistage method for continuously producing organic polyisocyanates, in particular diisocyanates.In a multistage method for continuously producing organic diisocyanates or polyisocyanates, the corresponding diisocyanates or...
|
|
JP2013170086A |
To provide a system and method for producing a fertilizer, which can reduce consumption of natural gas by effectively utilizing biomass gasification gas and improve the yield of urea, when urea as fertilizer is produced.This system 10 fo...
|
|
JP5274241B2 |
The invention relates to process for the preparation of a urea-comprising aqueous stream, that is suitable for use in a unit for the reduction of NOx in combustion engine exhaust gases, wherein the urea-comprising aqueous stream is separ...
|
|
JP5268934B2 |
The present invention relates to a process for preparing polyisocyanates by oligomerization of isocyanates.
|
|
JP5266499B2 |
The present invention provides a method represented by Scheme 1: wherein X represents I, Br, Cl, alkylsulfonate, or arylsulfonate; Z represents optionally substituted aryl, heteroaryl or alkenyl; L represents hydrogen or a negative charg...
|
|
JP2013158740A |
To provide a manufacturing method using an acid and/or acid-base catalyst that can be used as not only an acid catalyst but also an acid-base catalyst, can be supplied in the form of a homogeneous catalyst, and can exhibit suitable catal...
|
|
JP5264160B2 |
A compound comprising a substituent of the formula (II) is disclosed as an HIV protease inhibitor. Intermediates for making such compounds and processes for making such intermediates are also disclosed.
|
|
JP5259056B2 |
Biuret compounds (I) are new. Biuret compounds (I) of formula (R 2>-Y 1>-OCNH-R 1>-N-((CO-NH-R 3>-[Z-R 4>-Z-R 5>] a-NH)-CO-N-(R 2>-Y 1>-OCHN-R 1>)-(CONH-R 1>-NHCO-Y 1>-R 2>))-CONH-R 1>-NHCO-Y 1>-R 2>) are new. R 1>, R 3>-R 5>2-18C-alkyl,...
|
|
JP2013530182A |
Disclosed are novel thiourea or urea derivatives inhibitory of HIV activity. Also provided are a method for preparing the thiourea or urea derivatives, and a pharmaceutical composition for the prophylaxis or therapy of AIDS comprising th...
|
|
JP5226076B2 |
Crystallized diacetylenic compounds having certain crystallographic and other characteristics; diacetylenic compounds and mixtures crystallized from diacetylenic solutions; methods of preparing and identifying solvent systems for dissolv...
|
|
JP2013522171A |
The invention relates to compounds, pharmaceutical compositions and methods useful for treating cancer, systemic or chronic inflammation, rheumatoid arthritis, diabetes, obesity, T-cell mediated autoimmune disease, ischemia, and other co...
|
|
JP2013053166A |
To provide new crystallized diacetylenic compounds and to provide methods of preparing the compounds.This invention relates to: crystallized diacetylenic compounds having certain crystallographic and other characteristics; diacetylenic c...
|
|
JP5162460B2 |
The present invention is directed to a novel process for the preparation of benzo[e][1,2,4]triazepin-2-one derivatives, useful in the preparation of gastrin and cholecystokinin receptor ligands.
|
|
JP5125908B2 |
|
|
JP2013501052A |
Described herein is the DP2 antagonist [2′-(3-benzyl-1-ethyl-ureidomethyl)-6-methoxy-4′-trifluo
romethyl-biphenyl-3-yl]-acetic acid, or a pharmaceutically acceptable salt thereof. Also described are methods of preparing the DP2 antag...
|
|
JP5092289B2 |
|
|
JP5077973B2 |
|
|
JP5066852B2 |
|
|
JP5069222B2 |
The invention relates to a method for concentrating an aqueous ammonium carbamate stream, which has been formed in a process for the preparation of urea, has a pressure between 0.20 MPa and 0.9 MPa, a temperature between 35° C. and 95°...
|
|
JP5068177B2 |
A process for producing a substrate having a functionalised surface, which process comprises contacting the substrate with a carbene precursor, which carbene precursor is a compound of formula (III) or (IV) whose substituent groups are d...
|
|
JP5065271B2 |
A method for producing urea pellets having a narrow range of grain sizes and a sphericity >75% and a defined residual moisture ≰0.5% is provided. The method provides urea pellets having the properties required which meet the requiremen...
|
|
JP5064503B2 |
The present invention relates to compounds of formula I wherein R1, R2, R3, R4, R5, X, and n are as defined herein and the dotted line denotes an optional bond and pharmaceutically acceptable acid addition salts thereof. The compounds ar...
|
|
JP5052179B2 |
|
|
JP4994226B2 |
It is intended to enable more smooth operation in an apparatus for synthesizing urea by circumventing the downward flow of a urea synthesis solution which is a gas-liquid two-phase flow and stabilizing the flow of the urea synthesis solu...
|
|
JP2012140445A |
To provide a method of treating a condition associated with the CB-1 receptor, in particular obesity, by administering an effective amount of an aryl urea CB-1 receptor modulating compound to a subject in need of such treatment.This inve...
|
|
JP4955171B2 |
Disclosed are novel aromatic compounds of the formula (I) wherein G, X, Ar, L and Q are defined herein. The compounds are useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as...
|
|
JP4942262B2 |
The invention relates to a process for preparing a solution which comprises urea urethanes and is effective as a thixotropic agent, which involves reacting at least two structurally different monohydroxy compounds with an excess of toluy...
|
|
JP4928740B2 |
In a process and an apparatus for synthesizing urea which synthesize urea from ammonia and carbon dioxide, the operating condition can be grasped easily and with good accuracy. A process for synthesizing urea which includes: a reaction s...
|
|
JP4926334B2 |
A process for the continuous production of polyisocyanates (I) having a biuret structure by continuous reaction of an excess of organic diisocyanates having exclusively aliphatic and cycloaliphatic isocyanate groups with organic diamines...
|
|
JP4903697B2 |
The invention relates to a process for the preparation of urea from ammonia and carbon dioxide in a urea plant that contains a high-pressure synthesis section and one or more recovery section(s) at a lower pressure, the high-pressure syn...
|
|
JP4896157B2 |
Novel cyclohexylmethyl compounds corresponding to formula I wherein R1, R2, R3, R4 and R5, have the meanings given in the description. Pharmaceutical formulations containing these compounds, as well as a processes for preparing these com...
|
|
JP4884233B2 |
Production of a polyisocyanate composition (A) containing acylureas (I) involves reacting a starting composition (B) containing derivatives containing compounds (II) having at least two isocyanate functions at 50[deg]C or more with at le...
|
|
JP4852270B2 |
To effectively prepare granular urea that constantly has a moisture concentration of 0.3 wt% or less in the product and has a large grain load strength to be hardly crashed. In a granulating process for preparing granular urea from an aq...
|
|
JP2011528018A |
The present invention relates to azolin-2-ylamino compounds of formula (I), wherein A is a radical of the formulae (A.1) or (A.2), wherein * denotes the binding site and wherein the indices and variables are as defined in the description...
|
|
JP4809570B2 |
The present invention relates to compounds of the formula I, in which R<1>, R<2>, R<3>, R<4>, R<5>, R<6>, A, X, m and n have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compo...
|
|
JP4786100B2 |
Compounds containing carbodiimide units and carboxyl or carboxylate groups (compounds V), derived froma) aliphatic or araliphatic C4 to C20 polyisocyanates (component a)b) amino carboxylic acids or amino carboxylic salts (component b) an...
|
|
JP4773765B2 |
|
|
JP4731915B2 |
|
|
JP2011136912A |
To provide an acylurea modified polyisocyanate having approximately the same degree of performance as that of allophanate modified polyisocyanate hardly having coloration and having a low viscosity without using a catalyst such as a meta...
|
|
JP4723480B2 |
The present invention relates to salts having uronium cations and to a process for preparing same comprising alkylating urea C(O)(NR2)2 using an ester ARo.
|
|
JP4695383B2 |
|
